首页 > 最新文献

Revista Espanola de Anestesiologia y Reanimacion最新文献

英文 中文
Anestesia espinal continua para trasplante renal en una paciente de lupus con regurgitación mitral grave: informe de un caso 为一名患有严重二尖瓣返流的狼疮患者进行肾移植手术的连续脊髓麻醉:病例报告
IF 0.9 Q3 ANESTHESIOLOGY Pub Date : 2025-01-01 DOI: 10.1016/j.redar.2024.01.009
A.A. Pires , M.J. Correia , J. Sousa
Anaesthesia for kidney transplant in a patient with severe mitral regurgitation is a real challenge given the need for judicious haemodynamic management to avoid pulmonary oedema and maximise reperfusion of the transplanted organ. This is the first experience described in the literature of continuous spinal anaesthesia in a patient with chronic severe mitral regurgitation undergoing cadaver donor kidney transplant. Transthoracic echocardiography monitoring was used during the procedure to avoid aggravating the patient's mitral regurgitation. Intraoperatively, 17.5 ml/kg of crystalloids were administered and no vasopressors were required. Continuous spinal anaesthesia preserved haemodynamics and graft perfusion during the procedure.
{"title":"Anestesia espinal continua para trasplante renal en una paciente de lupus con regurgitación mitral grave: informe de un caso","authors":"A.A. Pires ,&nbsp;M.J. Correia ,&nbsp;J. Sousa","doi":"10.1016/j.redar.2024.01.009","DOIUrl":"10.1016/j.redar.2024.01.009","url":null,"abstract":"<div><div>Anaesthesia for kidney transplant in a patient with severe mitral regurgitation is a real challenge given the need for judicious haemodynamic management to avoid pulmonary oedema and maximise reperfusion of the transplanted organ. This is the first experience described in the literature of continuous spinal anaesthesia in a patient with chronic severe mitral regurgitation undergoing cadaver donor kidney transplant. Transthoracic echocardiography monitoring was used during the procedure to avoid aggravating the patient's mitral regurgitation. Intraoperatively, 17.5<!--> <!-->ml/kg of crystalloids were administered and no vasopressors were required. Continuous spinal anaesthesia preserved haemodynamics and graft perfusion during the procedure.</div></div>","PeriodicalId":46479,"journal":{"name":"Revista Espanola de Anestesiologia y Reanimacion","volume":"72 1","pages":"Article 101617"},"PeriodicalIF":0.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141047742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hipertensión intracraneal idiopática durante la gestación. A propósito de un caso 妊娠期特发性颅内高压。病例报告
IF 0.9 Q3 ANESTHESIOLOGY Pub Date : 2025-01-01 DOI: 10.1016/j.redar.2024.03.003
D. Revuelta , M. López-Baamonde , M. Vendrell , A. Plaza , T. Cobo , M. Magaldi
Idiopathic intracranial hypertension (IIH) is a condition characterized by elevated intracranial pressure (ICP) of unknown etiology, more prevalent in obese women of childbearing age. The management of IIH during pregnancy represents a multidisciplinary challenge, as medical treatment is contentious due to the fetal teratogenic risk, and the technically challenging placement of a ventriculoperitoneal shunt is hindered by the presence of the pregnant uterus. The goal of anesthetic management during childbirth is to maintain hemodynamic stability, cerebral perfusion pressure, and cerebral tissue oxygenation, while avoiding abrupt fluctuations in intracranial pressure. The choice of anesthetic technique is complex and depends on the assessment of risks and benefits associated with each technique, involving a decision between neuraxial anesthesia and general anesthesia.
We present the case of a pregnant woman with rapidly progressing IIH, approached in a multidisciplinary manner, whose anaesthetic management was technically challenging, resulting in a favourable outcome without subsequent complications.
{"title":"Hipertensión intracraneal idiopática durante la gestación. A propósito de un caso","authors":"D. Revuelta ,&nbsp;M. López-Baamonde ,&nbsp;M. Vendrell ,&nbsp;A. Plaza ,&nbsp;T. Cobo ,&nbsp;M. Magaldi","doi":"10.1016/j.redar.2024.03.003","DOIUrl":"10.1016/j.redar.2024.03.003","url":null,"abstract":"<div><div>Idiopathic intracranial hypertension (IIH) is a condition characterized by elevated intracranial pressure (ICP) of unknown etiology, more prevalent in obese women of childbearing age. The management of IIH during pregnancy represents a multidisciplinary challenge, as medical treatment is contentious due to the fetal teratogenic risk, and the technically challenging placement of a ventriculoperitoneal shunt is hindered by the presence of the pregnant uterus. The goal of anesthetic management during childbirth is to maintain hemodynamic stability, cerebral perfusion pressure, and cerebral tissue oxygenation, while avoiding abrupt fluctuations in intracranial pressure. The choice of anesthetic technique is complex and depends on the assessment of risks and benefits associated with each technique, involving a decision between neuraxial anesthesia and general anesthesia.</div><div>We present the case of a pregnant woman with rapidly progressing IIH, approached in a multidisciplinary manner, whose anaesthetic management was technically challenging, resulting in a favourable outcome without subsequent complications.</div></div>","PeriodicalId":46479,"journal":{"name":"Revista Espanola de Anestesiologia y Reanimacion","volume":"72 1","pages":"Article 101623"},"PeriodicalIF":0.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140762339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comentario sobre: «Bloqueo costoclavicular con inyección única vs doble: ensayo de no inferioridad»
IF 0.9 Q3 ANESTHESIOLOGY Pub Date : 2025-01-01 DOI: 10.1016/j.redar.2024.05.003
R.M. Sethuraman, S. Krishnakumar, S. Rajendran
{"title":"Comentario sobre: «Bloqueo costoclavicular con inyección única vs doble: ensayo de no inferioridad»","authors":"R.M. Sethuraman,&nbsp;S. Krishnakumar,&nbsp;S. Rajendran","doi":"10.1016/j.redar.2024.05.003","DOIUrl":"10.1016/j.redar.2024.05.003","url":null,"abstract":"","PeriodicalId":46479,"journal":{"name":"Revista Espanola de Anestesiologia y Reanimacion","volume":"72 1","pages":"Article 101639"},"PeriodicalIF":0.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143093345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efecto de propofol frente a sevoflurano en la oxigenación cerebral en la enfermedad de Moyamoya pediátrica. Estudio de espectroscopia de infrarrojo cercano 异丙酚与七氟醚对小儿 Moyamoya 病脑氧饱和度的影响。近红外光谱研究。
IF 0.9 Q3 ANESTHESIOLOGY Pub Date : 2025-01-01 DOI: 10.1016/j.redar.2024.03.009
J.R. Seshan, I. Kapoor, H. Prabhakar, C. Mahajan

Introduction and objectives

Anaesthesia during surgery for moyamoya disease (MMD) has different effects on cerebral physiology. Both sevoflurane and propofol have cerebral protective effects, albeit with different mechanisms. We used near infrared spectroscopy (NIRS) to observe the effect of sevoflurane and propofol on rSO2 in paediatric patients undergoing MMD surgery.

Materials and methods

We included paediatric patients ASA grade I aged between 1 and 18 years undergoing surgery for MMD over a period of 1 year (from 1 April 2018 to 1 April 2019). Patients were randomized to 2 groups: Group S (sevoflurane) and Group P (propofol). NIRS values were recorded at 5 time points: T1 (baseline) T2 (after preoxygenation), T3 (after induction), T4 (end of surgery), T5 (after extubation). One-way ANOVA was used for intra-group comparisons and two-way repeated measures ANOVA with Bonferroni correction were used for inter-group comparisons. P value < 0.05 was considered significant.

Results

A total of 20 patients were included in the study. The average age was 10.5 ± 4.3 years. The mean baseline rSO2 was 78.35 ± 10.58 and 77.95 ± 8.81 in the right and left hemispheres, respectively. In both groups, rSO2 values increased between baseline and anaesthesia induction and fell slightly at the end of surgery. The inter-group analysis showed no statistically significant change between rSO2 values.

Conclusion

Both sevoflurane and propofol maintain adequate rSO2 levels in children undergoing surgery for MMD.
Clinical trial registration number: CTRI/2018/04/013229 registered on 12.04.2018.
{"title":"Efecto de propofol frente a sevoflurano en la oxigenación cerebral en la enfermedad de Moyamoya pediátrica. Estudio de espectroscopia de infrarrojo cercano","authors":"J.R. Seshan,&nbsp;I. Kapoor,&nbsp;H. Prabhakar,&nbsp;C. Mahajan","doi":"10.1016/j.redar.2024.03.009","DOIUrl":"10.1016/j.redar.2024.03.009","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Anaesthesia during surgery for moyamoya disease (MMD) has different effects on cerebral physiology. Both sevoflurane and propofol have cerebral protective effects, albeit with different mechanisms. We used near infrared spectroscopy (NIRS) to observe the effect of sevoflurane and propofol on rSO<sub>2</sub> in paediatric patients undergoing MMD surgery.</div></div><div><h3>Materials and methods</h3><div>We included paediatric patients ASA grade I aged between 1 and 18 years undergoing surgery for MMD over a period of 1 year (from 1 April 2018 to 1 April 2019). Patients were randomized to 2 groups: Group S (sevoflurane) and Group P (propofol). NIRS values were recorded at 5 time points: T1 (baseline) T2 (after preoxygenation), T3 (after induction), T4 (end of surgery), T5 (after extubation). One-way ANOVA was used for intra-group comparisons and two-way repeated measures ANOVA with Bonferroni correction were used for inter-group comparisons. <em>P</em> value &lt;<!--> <!-->0.05 was considered significant.</div></div><div><h3>Results</h3><div>A total of 20 patients were included in the study. The average age was 10.5<!--> <!-->±<!--> <!-->4.3 years. The mean baseline rSO<sub>2</sub> was 78.35<!--> <!-->±<!--> <!-->10.58 and 77.95<!--> <!-->±<!--> <!-->8.81 in the right and left hemispheres, respectively. In both groups, rSO<sub>2</sub> values increased between baseline and anaesthesia induction and fell slightly at the end of surgery. The inter-group analysis showed no statistically significant change between rSO<sub>2</sub> values.</div></div><div><h3>Conclusion</h3><div>Both sevoflurane and propofol maintain adequate rSO<sub>2</sub> levels in children undergoing surgery for MMD.</div><div>Clinical trial registration number: CTRI/2018/04/013229 registered on 12.04.2018.</div></div>","PeriodicalId":46479,"journal":{"name":"Revista Espanola de Anestesiologia y Reanimacion","volume":"72 1","pages":"Article 101630"},"PeriodicalIF":0.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141411538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Síndrome de distrés respiratorio del adulto (SDRA) por reacción farmacológica con eosinofilia y síntomas sistémicos (DRESS) secundario a omeprazol: caso clínico y revisión de la literatura 继发于奥美拉唑的伴有嗜酸性粒细胞增多和全身症状的药物反应(DRESS)导致的成人呼吸窘迫综合征(ARDS):病例报告和文献综述
IF 0.9 Q3 ANESTHESIOLOGY Pub Date : 2024-12-01 DOI: 10.1016/j.redar.2024.01.002
D. Díaz Díaz , C. Olmos Mata , E. Palencia Herrejón , L. López Pérez
Eosinophilia in not an uncommon finding in the intensive care unit (ICU); however, DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) syndrome, which is characterized by a hypersensitivity reaction to drugs and manifests as eosinophilia, systemic involvement and maculopapular erythematous rash 2-6 weeks after exposure to the offending drug, is an exceptional occurrence. We present the first case described in the literature of DRESS syndrome with pulmonary involvement in the form of interstitial pneumonitis and persistent adult respiratory distress syndrome (ARDS) secondary to proton pump inhibitors (PPI). The patient made a good recovery after withdrawal of the offending drug and long-term treatment with systemic corticosteroids.
We also present a systematic review of all cases of DRESS with pulmonary involvement in the form of interstitial pneumonitis and cases of PPI-induced DRESS published to date; none of these describe pulmonary involvement.
嗜酸性粒细胞增多症在重症监护病房(ICU)并不罕见;然而,DRESS(嗜酸性粒细胞增多和全身性症状的药物反应)综合征是一种罕见的情况,其特征是对药物的超敏反应,表现为嗜酸性粒细胞增多、全身受累和暴露于致病药物2-6周后出现斑疹丘疹。我们报告了文献中第一例以间质性肺炎和继发于质子泵抑制剂(PPI)的持续性成人呼吸窘迫综合征(ARDS)形式累及肺部的DRESS综合征。患者停药后恢复良好,长期全身性糖皮质激素治疗。我们还对所有以间质性肺炎形式累及肺部的DRESS病例和迄今发表的ppi诱导的DRESS病例进行了系统回顾;这些都没有描述肺部受累。
{"title":"Síndrome de distrés respiratorio del adulto (SDRA) por reacción farmacológica con eosinofilia y síntomas sistémicos (DRESS) secundario a omeprazol: caso clínico y revisión de la literatura","authors":"D. Díaz Díaz ,&nbsp;C. Olmos Mata ,&nbsp;E. Palencia Herrejón ,&nbsp;L. López Pérez","doi":"10.1016/j.redar.2024.01.002","DOIUrl":"10.1016/j.redar.2024.01.002","url":null,"abstract":"<div><div>Eosinophilia in not an uncommon finding in the intensive care unit (ICU); however, DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) syndrome, which is characterized by a hypersensitivity reaction to drugs and manifests as eosinophilia, systemic involvement and maculopapular erythematous rash 2-6 weeks after exposure to the offending drug, is an exceptional occurrence. We present the first case described in the literature of DRESS syndrome with pulmonary involvement in the form of interstitial pneumonitis and persistent adult respiratory distress syndrome (ARDS) secondary to proton pump inhibitors (PPI). The patient made a good recovery after withdrawal of the offending drug and long-term treatment with systemic corticosteroids.</div><div>We also present a systematic review of all cases of DRESS with pulmonary involvement in the form of interstitial pneumonitis and cases of PPI-induced DRESS published to date; none of these describe pulmonary involvement.</div></div>","PeriodicalId":46479,"journal":{"name":"Revista Espanola de Anestesiologia y Reanimacion","volume":"71 10","pages":"Pages 763-770"},"PeriodicalIF":0.9,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140462377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Excursión diafragmática con imagen Doppler tisular en modo M color 通过彩色 M 型组织多普勒成像观察膈肌偏移
IF 0.9 Q3 ANESTHESIOLOGY Pub Date : 2024-12-01 DOI: 10.1016/j.redar.2023.04.007
I. Cheong
{"title":"Excursión diafragmática con imagen Doppler tisular en modo M color","authors":"I. Cheong","doi":"10.1016/j.redar.2023.04.007","DOIUrl":"10.1016/j.redar.2023.04.007","url":null,"abstract":"","PeriodicalId":46479,"journal":{"name":"Revista Espanola de Anestesiologia y Reanimacion","volume":"71 10","pages":"Page 771"},"PeriodicalIF":0.9,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139540176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validez de la velocidad estimada de onda de pulso aórtica medida durante la prueba de caminata de 6 minutos para predecir la capacidad anaeróbica antes de la cirugía mayor no cardiaca 在非心脏大手术前6分钟步行试验中测量的预测厌氧能力的估计主动脉脉冲波速度的有效性
IF 0.9 Q3 ANESTHESIOLOGY Pub Date : 2024-12-01 DOI: 10.1016/j.redar.2024.04.001
J. Ripollés-Melchor , M.I. Monge García , A. Ruiz-Escobar , E. Sáez-Ruiz , B. Algar-Yañez , A. Abad-Motos , A. Abad-Gurumeta

Background

This study aimed to assess the efficacy of estimated preoperative aortic pulse wave velocity (AoPWV) to discriminate between low and high 6 min walk test (6MWT) distance in patients awaiting major non-cardiac surgery.

Methods

Prospective observational study in 133 patients ungergoing non cardiac surgery. AoPWV and the distance walked during a 6MWT were assessed. Receiver operating characteristic (ROC) curve analysis was used to determine two different AoPWV cut-points for predicting a distance of 427 m in the 6MWT. We also calculated lower and upper AoPWV cut-points (probability ≥ 0.75) for predicting a distance of < 427 m, ≥ 427 m, and also 563 m in the 6MWT.

Results

The ROC curve analysis for the < 427 m distance revealed an area under the curve (AUC) of 0.68 (95% confidence interval: 0.56–-0.79) and an AUC of 0.72 (95% confidence interval: 0.61-0.83) for > 563 m. Patients with AoPWV > 10.97 m/s should be considered higher risk, while those with < 9.42 m/s can be considered low risk.

Conclusions

AoPWV is a simple, non-invasive, useful clinical tool for identifying and stratifying patients awaiting major non-cardiac surgery. In situations of clinical uncertainty, additional measures should be taken to assess the risk.
本研究旨在评估预估的术前主动脉脉波速度(AoPWV)在等待重大非心脏手术患者6分钟步行试验(6MWT)距离高低之间的区分作用。方法对133例非心脏手术患者进行前瞻性观察研究。评估AoPWV和6MWT期间行走距离。使用受试者工作特征(ROC)曲线分析确定两个不同的AoPWV切点,用于预测6MWT中427 m的距离。我们还计算了AoPWV下限和上限切割点(概率≥0.75),用于预测<的距离;427米,≥427米,6MWT为563米。结果ROC曲线分析表明:427 m距离显示曲线下面积(AUC)为0.68(95%可信区间:0.56—0.79),曲线下面积(AUC)为0.72(95%可信区间:0.61—0.83);563米。AoPWV患者>;10.97 m/s应考虑高风险,而<;9.42 m/s可视为低风险。结论saopwv是一种简便、无创、有效的非心脏大手术患者鉴别和分层工具。在临床不确定的情况下,应采取额外的措施来评估风险。
{"title":"Validez de la velocidad estimada de onda de pulso aórtica medida durante la prueba de caminata de 6 minutos para predecir la capacidad anaeróbica antes de la cirugía mayor no cardiaca","authors":"J. Ripollés-Melchor ,&nbsp;M.I. Monge García ,&nbsp;A. Ruiz-Escobar ,&nbsp;E. Sáez-Ruiz ,&nbsp;B. Algar-Yañez ,&nbsp;A. Abad-Motos ,&nbsp;A. Abad-Gurumeta","doi":"10.1016/j.redar.2024.04.001","DOIUrl":"10.1016/j.redar.2024.04.001","url":null,"abstract":"<div><h3>Background</h3><div>This study aimed to assess the efficacy of estimated preoperative aortic pulse wave velocity (AoPWV) to discriminate between low and high 6<!--> <!-->min walk test (6MWT) distance in patients awaiting major non-cardiac surgery.</div></div><div><h3>Methods</h3><div>Prospective observational study in 133 patients ungergoing non cardiac surgery. AoPWV and the distance walked during a 6MWT were assessed. Receiver operating characteristic (ROC) curve analysis was used to determine two different AoPWV cut-points for predicting a distance of 427 m in the 6MWT. We also calculated lower and upper AoPWV cut-points (probability ≥<!--> <!-->0.75) for predicting a distance of &lt;<!--> <!-->427<!--> <!-->m, ≥<!--> <!-->427<!--> <!-->m, and also 563<!--> <!-->m in the 6MWT.</div></div><div><h3>Results</h3><div>The ROC curve analysis for the &lt;<!--> <!-->427<!--> <!-->m distance revealed an area under the curve (AUC) of 0.68 (95% confidence interval: 0.56–-0.79) and an AUC of 0.72 (95% confidence interval: 0.61-0.83) for &gt;<!--> <!-->563<!--> <!-->m. Patients with AoPWV &gt;<!--> <!-->10.97<!--> <!-->m/s should be considered higher risk, while those with &lt;<!--> <!-->9.42<!--> <!-->m/s can be considered low risk.</div></div><div><h3>Conclusions</h3><div>AoPWV is a simple, non-invasive, useful clinical tool for identifying and stratifying patients awaiting major non-cardiac surgery. In situations of clinical uncertainty, additional measures should be taken to assess the risk.</div></div>","PeriodicalId":46479,"journal":{"name":"Revista Espanola de Anestesiologia y Reanimacion","volume":"71 10","pages":"Pages 710-718"},"PeriodicalIF":0.9,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142758767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Uso de fluidoterapia en el periodo perioperatorio en pacientes adultos: revisión narrativa 成人患者术后使用液体疗法:叙述综述
IF 0.9 Q3 ANESTHESIOLOGY Pub Date : 2024-12-01 DOI: 10.1016/j.redar.2024.04.003
M.J. Colomina , P. Galán Menéndez , J. Ripollés-Melchor
The administration of intravenous fluids is the most common intervention in hospitalized patients in the perioperative setting and critical care units. The aim of this narrative review is to provide an overview of balanced solutions in fluid therapy in the perioperative period in adult patients, and to review new trends and solutions in fluid therapy.
The evidence was grouped into 3 areas: intraoperative fluid administration, fluid administration in the critically ill patient and the relevance / benefit of balanced crystalloid solutions.
Although in recent years there has been an improvement in high-quality published studies, the scientific evidence regarding choice of fluid, dose and rate of administration is still limited. The choice of fluid therapy during the perioperative period must be individualized, considering patient-specific factors, the nature of the surgery, expected fluid loss and other relevant factors. Finally, more robust clinical evidence and training of clinicians should be of utter importance.
静脉输液是围手术期和重症监护病房住院患者最常见的干预措施。这篇叙述性综述的目的是概述成人患者围手术期液体治疗的平衡解决方案,并回顾液体治疗的新趋势和解决方案。证据分为3个方面:术中液体给药、危重患者液体给药和平衡晶体溶液的相关性/益处。尽管近年来发表的高质量研究有所改善,但关于液体选择、剂量和给药速度的科学证据仍然有限。围手术期液体疗法的选择必须个体化,考虑患者的具体因素、手术的性质、预期的液体流失和其他相关因素。最后,更有力的临床证据和临床医生的培训应该是绝对重要的。
{"title":"Uso de fluidoterapia en el periodo perioperatorio en pacientes adultos: revisión narrativa","authors":"M.J. Colomina ,&nbsp;P. Galán Menéndez ,&nbsp;J. Ripollés-Melchor","doi":"10.1016/j.redar.2024.04.003","DOIUrl":"10.1016/j.redar.2024.04.003","url":null,"abstract":"<div><div>The administration of intravenous fluids is the most common intervention in hospitalized patients in the perioperative setting and critical care units. The aim of this narrative review is to provide an overview of balanced solutions in fluid therapy in the perioperative period in adult patients, and to review new trends and solutions in fluid therapy.</div><div>The evidence was grouped into 3 areas: intraoperative fluid administration, fluid administration in the critically ill patient and the relevance / benefit of balanced crystalloid solutions.</div><div>Although in recent years there has been an improvement in high-quality published studies, the scientific evidence regarding choice of fluid, dose and rate of administration is still limited. The choice of fluid therapy during the perioperative period must be individualized, considering patient-specific factors, the nature of the surgery, expected fluid loss and other relevant factors. Finally, more robust clinical evidence and training of clinicians should be of utter importance.</div></div>","PeriodicalId":46479,"journal":{"name":"Revista Espanola de Anestesiologia y Reanimacion","volume":"71 10","pages":"Pages 748-759"},"PeriodicalIF":0.9,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142758774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quiste filar en ecografía previa a raquianestesia neonatal 新生儿脊髓麻醉前超声波显示的纤毛囊肿
IF 0.9 Q3 ANESTHESIOLOGY Pub Date : 2024-12-01 DOI: 10.1016/j.redar.2023.07.008
R. Eizaga Rebollar , A. Alonso Ojembarrena
{"title":"Quiste filar en ecografía previa a raquianestesia neonatal","authors":"R. Eizaga Rebollar ,&nbsp;A. Alonso Ojembarrena","doi":"10.1016/j.redar.2023.07.008","DOIUrl":"10.1016/j.redar.2023.07.008","url":null,"abstract":"","PeriodicalId":46479,"journal":{"name":"Revista Espanola de Anestesiologia y Reanimacion","volume":"71 10","pages":"Page 762"},"PeriodicalIF":0.9,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139539171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Terapia hemodinámica guiada por objetivos mediante la administración de líquidos para optimizar el volumen sistólico: metaanálisis de ensayos controlados aleatorizados 利用输液优化脑卒中容量的目标引导血流动力学疗法:随机对照试验荟萃分析
IF 0.9 Q3 ANESTHESIOLOGY Pub Date : 2024-12-01 DOI: 10.1016/j.redar.2024.04.004
J. Ripollés-Melchor , Á.V. Espinosa , P. Fernández-Valdes-Bango , R. Navarro-Pérez , A. Abad-Motos , J.V. Lorente , M.J. Colomina , E. Sáez-Ruiz , A. Abad-Gurumeta , M.I. Monge-García

Objective

To evaluate the clinical impact of optimizing stroke volume (SV) through fluid administration as part of goal-directed hemodynamic therapy (GDHT) in adult patients undergoing elective major abdominal surgery.

Methods

This systematic review and meta-analysis was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement and was registered in the PROSPERO database in January 2024. The intervention was defined as intraoperative GDHT based on the optimization or maximization of SV through fluid challenges, or by using dynamic indices of fluid responsiveness, including stroke volume variation, pulse pressure variation, and plethysmography variation index compared to usual fluid management. The primary outcome was postoperative complications. Secondary outcome variables included postoperative acute kidney injury (AKI), length of stay (LOS), intraoperative fluid administration, and 30-day mortality.

Results

A total of 29 randomized controlled trials (RCTs) met the inclusion criteria. There were no significant differences in the incidence of postoperative complications (RR 0.89; 95% CI, 0.78 to 1.00), postoperative AKI (OR 0.97; (95% IC, 0.55 to 1.70), and mortality (OR 0.80; 95% CI, 0.50 to 1.29). GDHT was associated with a reduced LOS compared to usual care (SMD: −0.17 [−0.32; - 0.03]). The subgroup in which hydroxyethyl starch was used for hemodynamic optimization was associated with fewer complications (RR 0.79; 95% CI, 0.65 to 0.94), whereas the subgroup of patients in whom crystalloids were used was associated with an increased risk of postoperative complications (RR 1.08; 95% CI, 1.04 to 1.12).

Conclusions

In adults undergoing major surgery, goal-directed hemodynamic therapy focused on fluid-based stroke volume optimization did not reduce postoperative morbidity and mortality.
目的评价通过液体给药优化脑卒中容量(SV)作为目标导向血流动力学治疗(GDHT)的一部分在成人择期腹部大手术中的临床效果。方法本研究按照PRISMA (Preferred Reporting Items for systematic Reviews and meta-analysis)声明进行系统评价和荟萃分析,并于2024年1月在PROSPERO数据库中注册。干预被定义为术中GDHT,基于通过流体挑战优化或最大化SV,或通过使用流体反应性的动态指标,包括与常规液体管理相比的脑卒中容积变化、脉压变化和容积图变化指数。主要结局为术后并发症。次要结局变量包括术后急性肾损伤(AKI)、住院时间(LOS)、术中给液和30天死亡率。结果共有29项随机对照试验(RCTs)符合纳入标准。两组术后并发症发生率差异无统计学意义(RR 0.89;95% CI, 0.78 ~ 1.00),术后AKI (OR 0.97;(95% IC, 0.55 ~ 1.70)和死亡率(OR 0.80;95% CI, 0.50 - 1.29)。与常规治疗相比,GDHT与LOS降低相关(SMD: - 0.17 [- 0.32;- 0.03])。羟乙基淀粉用于血流动力学优化的亚组并发症较少(RR 0.79;95% CI, 0.65 ~ 0.94),而使用晶体药物的患者亚组与术后并发症风险增加相关(RR 1.08;95% CI, 1.04 - 1.12)。结论在接受大手术的成年人中,以液体为基础的卒中容量优化为重点的目标导向血流动力学治疗并没有降低术后发病率和死亡率。
{"title":"Terapia hemodinámica guiada por objetivos mediante la administración de líquidos para optimizar el volumen sistólico: metaanálisis de ensayos controlados aleatorizados","authors":"J. Ripollés-Melchor ,&nbsp;Á.V. Espinosa ,&nbsp;P. Fernández-Valdes-Bango ,&nbsp;R. Navarro-Pérez ,&nbsp;A. Abad-Motos ,&nbsp;J.V. Lorente ,&nbsp;M.J. Colomina ,&nbsp;E. Sáez-Ruiz ,&nbsp;A. Abad-Gurumeta ,&nbsp;M.I. Monge-García","doi":"10.1016/j.redar.2024.04.004","DOIUrl":"10.1016/j.redar.2024.04.004","url":null,"abstract":"<div><h3>Objective</h3><div>To evaluate the clinical impact of optimizing stroke volume (SV) through fluid administration as part of goal-directed hemodynamic therapy (GDHT) in adult patients undergoing elective major abdominal surgery.</div></div><div><h3>Methods</h3><div>This systematic review and meta-analysis was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement and was registered in the PROSPERO database in January 2024. The intervention was defined as intraoperative GDHT based on the optimization or maximization of SV through fluid challenges, or by using dynamic indices of fluid responsiveness, including stroke volume variation, pulse pressure variation, and plethysmography variation index compared to usual fluid management. The primary outcome was postoperative complications. Secondary outcome variables included postoperative acute kidney injury (AKI), length of stay (LOS), intraoperative fluid administration, and 30-day mortality.</div></div><div><h3>Results</h3><div>A total of 29 randomized controlled trials (RCTs) met the inclusion criteria. There were no significant differences in the incidence of postoperative complications (RR 0.89; 95% CI, 0.78 to 1.00), postoperative AKI (OR 0.97; (95% IC, 0.55 to 1.70), and mortality (OR 0.80; 95% CI, 0.50 to 1.29). GDHT was associated with a reduced LOS compared to usual care (SMD: −0.17 [−0.32; - 0.03]). The subgroup in which hydroxyethyl starch was used for hemodynamic optimization was associated with fewer complications (RR 0.79; 95% CI, 0.65 to 0.94), whereas the subgroup of patients in whom crystalloids were used was associated with an increased risk of postoperative complications (RR 1.08; 95% CI, 1.04 to 1.12).</div></div><div><h3>Conclusions</h3><div>In adults undergoing major surgery, goal-directed hemodynamic therapy focused on fluid-based stroke volume optimization did not reduce postoperative morbidity and mortality.</div></div>","PeriodicalId":46479,"journal":{"name":"Revista Espanola de Anestesiologia y Reanimacion","volume":"71 10","pages":"Pages 719-731"},"PeriodicalIF":0.9,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141851595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Revista Espanola de Anestesiologia y Reanimacion
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1